Drug firms will be barred from extortionately raising NHS drug prices

UK Health Secretary Jeremy Hunt has unveiled plans to close a loophole that permits drugmakers to drastically raise prices, Daily Mail reported.

Previously, drugmakers were able to legally bypass the NHS’ pricing cap rules by dropping the brand name and using a generic name.

“No pharmaceutical company should be exploiting the NHS,” a health department spokesman said, adding “the Competition and Markets Authority is already investigating a potential abuse of generics pricing, and as part of a public consultation we have asked for views on government powers to limit the prices of generic medicines where there is no competitive market.”

Read more on the story at FirstWordPharma.

Tagged with

Published 20. September 2016 in News UK